UPDATE - SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 17, 2015

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who sold Allergan, Inc. ("Allergan" or the "Company") AGN securities between February 25, 2014 and April 21, 2014.

For more information, click here: http://zlk.9nl.com/allergan.

The complaint stems from concerns that Valeant Pharmaceuticals International, Inc. ("Valeant") unlawfully indicated to Pershing Square Asset Management L.P. that it would make a tender offer for Allergan, allowing Pershing Square to trade on this non-public information by buying an approximate 9.7% stake in Allergan during the Class Period.

If you suffered a loss in Allergan you have until February 17, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/allergan.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.